Crestline Management’s CVS Health CVS Stock Holding History

Crestline Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-56,500	Closed	-$3.08M	–	87
2019 Q2	$3.08M	Buy	+56,500	New	+$3.04M	0.41%	36

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Crestline Management's CVS Position: Q3 2019 in Review

Crestline Management sold out of CVS Health (CVS) in Q3 2019, closing a stake of 56,500 shares — an estimated $3.08M sold.

Crestline Management first reported a position in CVS in Q2 2019 and held it in 1 quarter. The position peaked at $3.08M in Q2 2019. 1,683 funds tracked by Wall St. Rank hold CVS as of Q3 2019.

Crestline Management reported no remaining CVS Health position as of Q3 2019 after selling out during the quarter.
Crestline Management sold 56,500 CVS Health shares in Q3 2019, an estimated $3.08M.
Crestline Management first reported a position in CVS Health in Q2 2019 and held it in 1 quarter.
Crestline Management's CVS Health position peaked at $3.08M in Q2 2019.
1,683 funds tracked by Wall St. Rank held CVS Health as of Q3 2019.

Based on Crestline Management's 13F filing for Q3 2019, filed 13 Nov 2019.